Home › Chronic Kidney Disease › Florida › Brandon
Chronic Kidney Disease clinical trials in Brandon, FL
3 studies for Chronic Kidney Disease are looking for participants at sites in and around Brandon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Riverview · 6 mi away
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
RecruitingPhase 3
- Research Site, Riverview · 6 mi away
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Riverview · 6 mi away
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY16 studies
- Boston, MA15 studies
- Houston, TX15 studies
- Philadelphia, PA15 studies
- Dallas, TX15 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Kansas City, MO9 studies
- Durham, NC9 studies
- San Antonio, TX8 studies
- Washington, DC8 studies
Other studies in Brandon
- Major Depressive Disorder6 studies
- Disorders of Excessive Somnolence6 studies
- High Blood Pressure5 studies
- Sleep Disorders5 studies
- Steatotic Liver Disease4 studies
- Lupus4 studies
- Narcolepsy4 studies
- Idiopathic Hypersomnia4 studies
- COPD3 studies
- Heart Failure3 studies
- Depression3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.